search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Implementation of a decision aid for the treatment of localized prostate cancer


- candidate number26765
- NTR NumberNTR6245
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR27-feb-2017
- Secondary IDsCZ-201300071 
- Public TitleImplementation of a decision aid for the treatment of localized prostate cancer
- Scientific TitleImplementation and effect of a decision aid for localized prostate cancer; part of the multiregional JIPPA study
- ACRONYM
- hypothesisThe implementation rate of the decision aid in daily care is expected to depend on barriers perceived by care providers and/or patients.
Use of the decision aid is expecetd to decrease decisional conflict and increase knowledge in patients.
- Healt Condition(s) or Problem(s) studiedProstate cancer, Choice
- Inclusion criteriaMen with localized prostate cancer
Eligible for two or more treatment options
- Exclusion criteriaInsufficient knowledge of the Dutch language
- mec approval receivedno
- multicenter trialyes
- randomisedno
- groupParallel
- Type2 or more arms, non-randomized
- Studytypeintervention
- planned startdate 1-feb-2013
- planned closingdate1-jun-2017
- Target number of participants250
- InterventionsCare providers present a decision aid to their patients with prostate cancer to involve them in the choice of their treatment.
Care providers and patients fill out questionnaires.
A control group of patients receive usual care without decision aid. They also fill out questionnaires.
- Primary outcomeImplementation rate of the decision aid in routine care
Barriers and facilitators for decision aid use
- Secondary outcomeEffect of the Decision aid on:
Decisional conflict
Prostate cancer knowledge
- TimepointsPatient questionnaires were filled out after the treatment choice was made but before the treatment was carried out.
Care provider questionnaires were filled out after about nine months of using the decision aid
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDr. Julia van Tol-Geerdink
- CONTACT for SCIENTIFIC QUERIESDr. Julia van Tol-Geerdink
- Sponsor/Initiator Radboud University Medical Center Nijmegen
- Funding
(Source(s) of Monetary or Material Support)
CZ Fonds
- Publicationsvan Tol-Geerdink JJ, van Oort IM, Somford DM, Wijburg CJ, Geboers AD, Stalmeier PFM. Caregiversí and patientsí responses to the implementation of a decision aid for prostate cancer treatment. Med Decision Making 36 (3): E107, 2016.
van Tol-Geerdink JJ, Cuypers M, Al-Itejawi HHM, van Uden-Kraan CF, de Vries M, Stalmeier PFM. Implementation and effect of three Dutch decision aids for prostate cancer; Results from the JIPPA study. Eur Urol S15 (13), E1580-1581, 2016
- Brief summaryTo address the limited use of decision support in oncology daily practice, the implementation of a decision aids (DA) is studied in patients with localized prostate cancer who had more than one treatment option (surgery, external radiotherapy, brachytherapy and/or active surveillance). This study focusses primarily on the barriers and facilitators for DA use.
Both care providers and patients fill out questionnaires on decision making and on the use of the DA. The implementation rate was calculated as the portion of eligible patients that received a DA, using national cancer registry data on the number of eligible patients per hospital.
In addition, the effect of the DA is studied by comparing the intervention group (receiving usual care plus DA) with a control group (receiving usual care without DA).
- Main changes (audit trail)
- RECORD27-feb-2017 - 9-jul-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl